Skip to main content English


Gerd Jomrich
Priv. Doz. Dr. Gerd Jomrich

Department of General Surgery (Division of Visceral Surgery)
Position: Consultant

ORCID: 0000-0002-7294-4831
T +43 1 40400 56210

Further Information


Barrett Esophagus; Carcinoma, Pancreatic Ductal; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Fibroblast Growth Factors; Gastrectomy; Gastroesophageal Reflux; Inflammation; Neoadjuvant Therapy; Pancreatic Cancer; Pancreatic Neoplasms; Pancreaticoduodenectomy; Pancreatitis; Receptors, Fibroblast Growth Factor; Translational Medical Research

Research interests

  • Local and Systemic Inflammation in Gastric, Esophageal and Pancreatic Cancer
  • Molecular Peritoneal Staging in Gastric, Esophageal and Pancreatic Cancer
  • Expression of Fibroblast Growth Factors and its Receptors in (neoadjuvantly treated) Gastric, Esophageal and Pancreatic Cancer
  • Prognostic Value of Preoperative Laboratory Results in Gastric, Esophageal and Pancreatic Cancer
  • Biobanking: Establishing a Biobank for Upper-GI and Pancreatic Malignancies
  • Perioperative Stress-Induced Biomarkers on Stress Signaling Receptors in Esophageal and Pancreatic Cancer Patients

Techniques, methods & infrastructure

  • Upper-GI Biobank
  • Pancreatic Cancer Biobank
  • Analyzing Esophageal and Pancreatic Cancer RNASeq Data from TCGA (The Cancer Genome Atlas)
  • Immunohistochemistry (IHC)
  • Quantitative RT-PCR
  • Retrospective Clinical Studies

Selected publications

  1. Jormich G. et al., 2022. Expression of programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand (PD-L1) in adenocarcinomas of the gastroesophageal junction change significantly after neoadjuvant treatment. Available at:
  2. Jomrich, G. et al., 2021. High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma. Available at:
  3. Jomrich, G. et al., 2019. Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas.Available at:
  4. Jomrich, G. et al. (2019) ‘Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection’, Journal of Gastrointestinal Surgery, 24(3), pp. 610–618. Available at:
  5. Jomrich, G. et al. (2019) ‘High Mean Corpuscular Volume Predicts Poor Outcome for Patients With Gastroesophageal Adenocarcinoma’, Annals of Surgical Oncology, 26(4), pp. 976–985. Available at: